Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin Rundi MaGang SongTingxi Yu Original Article Open access 21 November 2007 Pages: 559 - 568
c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells Eiko TakadaKikumi HataJunichiro Mizuguchi Original Article 17 November 2007 Pages: 569 - 576
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines Noriaki KitadaKohji TakaraTeruyoshi Yokoyama Original Article 21 November 2007 Pages: 577 - 584
Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines Songyot AnuchapreedaSingkome TimaPornngarm Limtrakul Original Article 23 November 2007 Pages: 585 - 594
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP) Saška MarcziLjubica Glavaš-ObrovacMladen Žinić Original Article 23 November 2007 Pages: 595 - 604
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice Laura K. ZerbeLori D. Dwyer-NieldAlvin M. Malkinson Original Article 21 November 2007 Pages: 605 - 620
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft M. BigioniA. BenzoM. Binaschi Original Article 24 November 2007 Pages: 621 - 629
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors Laura Q. M. ChowS. Gail EckhardtLia Gore Original Article 06 December 2007 Pages: 631 - 646
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas T. Clark GamblinMerrill J. EgorinDavid L. Bartlett Original Article 27 November 2007 Pages: 647 - 653
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide Franca FormelliElena CavadiniStefano Persiani Original Article 08 December 2007 Pages: 655 - 665
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel Rosalba TorrisiAlessandra BalduzziMarco Colleoni Original Article 07 December 2007 Pages: 667 - 672
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma M. ReniR. BerardiS. Grisanti Original Article 03 January 2008 Pages: 673 - 678
Pharmacokinetics of heated intraperitoneal oxaliplatin G. FerronS. DattezE. Chatelut Original Article 15 December 2007 Pages: 679 - 683
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients Jens AtzpodienKerstin TerflothMartina Reitz Original Article 15 December 2007 Pages: 685 - 688
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity Hyo Jin KangHee Jeong KimInsoo Bae Original Article 12 December 2007 Pages: 689 - 697
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy Danny RogersKaren D. NylanderNina F. Schor Original Article 13 March 2008 Pages: 699 - 706
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4 Z.-Y. ZhangB. M. KingY. N. Wong Original Article 23 April 2008 Pages: 707 - 716
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation Alessandra FabiGiulio MetroFrancesco Cognetti Clinical Trial Report 06 December 2007 Pages: 717 - 725
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors William SchelmanSherry Morgan-MeadowsGeorge Wilding Clinical Trial Report 03 January 2008 Pages: 727 - 733
Imatinib inhibition of fludarabine uptake in T-lymphocytes Erica L. WoodahlJoanne WangJeannine S. McCune Short Communication 15 November 2007 Pages: 735 - 739
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient Massimo GentileEugenio LuciaFortunato Morabito Short Communcation 07 December 2007 Pages: 741 - 743